Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Pacira Pharmaceuticals Company Profile (NASDAQ:PCRX)

Consensus Ratings for Pacira Pharmaceuticals (NASDAQ:PCRX) (?)
Ratings Breakdown: 1 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.89)
Consensus Price Target: $106.93 (0.46% upside)

Current Analysts' Coverage Summary for Pacira Pharmaceuticals (NASDAQ:PCRX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/17/2014ZacksReiterated RatingOutperform -> Outperform$125.00ViewTweet This Rating  Share This Rating on StockTwits
8/1/2014WedbushBoost Price Target$98.00 -> $110.00ViewTweet This Rating  Share This Rating on StockTwits
8/1/2014Canaccord GenuityBoost Price Target$114.00ViewTweet This Rating  Share This Rating on StockTwits
8/1/2014Jefferies GroupReiterated RatingBuy$86.00 -> $109.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2014Brean CapitalBoost Price TargetBuy$86.00 -> $111.00ViewTweet This Rating  Share This Rating on StockTwits
7/17/2014Bank of AmericaReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
7/16/2014BarclaysBoost Price TargetOverweight$85.00 -> $107.00ViewTweet This Rating  Share This Rating on StockTwits
6/17/2014JMP SecuritiesInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
6/2/2014Goldman SachsInitiated CoverageBuy$93.00ViewTweet This Rating  Share This Rating on StockTwits
4/1/2014Piper JaffrayUpgradeNeutral -> Overweight$75.00 -> $84.00ViewTweet This Rating  Share This Rating on StockTwits
3/18/2014National Alliance SecuritiesInitiated CoverageBuy$109.41ViewTweet This Rating  Share This Rating on StockTwits
5/10/2013TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/25/2012 forward)
Discuss Pacira Pharmaceuticals